Search results
Results from the WOW.Com Content Network
A product can be a drug, a cosmetic, or a combination of both, but the term "cosmeceutical" has no meaning under the law". [6] Additionally, the FDA states that: "Food, Drug and Cosmetic Act defines drugs as those products that cure, treat, mitigate or prevent disease or that affect the structure or function of the human body.
Pages in category "Cosmetics companies of the United States" The following 90 pages are in this category, out of 90 total. This list may not reflect recent changes. A.
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Shares of the Waltham, Massachusetts-based company were down 47.3%, to $1.7 in premarket trade, among the worse performing stocks across U.S. stock exchanges. The company said the FDA did not ...
The S&P 500 is a stock market index maintained by S&P Dow Jones Indices. It comprises 503 common stocks which are issued by 500 large-cap companies traded on the American stock exchanges (including the 30 companies that compose the Dow Jones Industrial Average). The index includes about 80 percent of the American market by capitalization.
A company’s dividend yield can be calculated by taking the annual dividend per share and dividing by the current stock price. Today, an S&P 500 index fund pays a dividend yield of about 1.3 percent.
As of 2019, twelve of top 20 biopharmaceutical companies in the world has U.S. headquarters in the state. [9] [10] Below is a list of notable New York metropolitan area biotechnology and pharmaceutical corporations, including companies with either global or U.S. headquarters in the metropolitan region encompassing and surrounding New York City.
The company owns three brands, Biossance and Pipette, for beauty and skincare, and Purecane, a sugar substitute. The company went public on NASDAQ on September 28, 2010 (AMRS). [5] In November 2011, Amyris acquired Lansing, Michigan-based renewable chemicals and products company, Draths Corporation, for $7 million in stock. [6]